IS5727A - Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness - Google Patents

Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness

Info

Publication number: IS5727A
Authority: IS; Iceland
Prior art keywords: ghs; serm; selective; growth hormone; skeletal muscle
Prior art date: 1998-06-16

Application number

IS5727A

Other languages

Icelandic (is)

Inventor

Zhu Ke Hua

Li Mei

Codetta Pan Lydia

Duane Thompson David

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

2000-11-24

Publication date

2000-11-24

2000-11-24 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2000-11-24 Publication of IS5727A publication Critical patent/IS5727A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IS5727A 1998-06-16 2000-11-24 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness IS5727A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8942498P	1998-06-16	1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en)	1998-06-16	1999-05-03	Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number	Publication Date
IS5727A true IS5727A (en)	2000-11-24

Family

ID=22217565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5727A IS5727A (en)	1998-06-16	2000-11-24	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness

Country Status (29)

Country	Link
EP (1)	EP1085867A1 (en)
JP (1)	JP2002518328A (en)
KR (1)	KR20010052817A (en)
CN (1)	CN1305378A (en)
AP (1)	AP9901581A0 (en)
AR (1)	AR018868A1 (en)
AU (1)	AU3342099A (en)
BG (1)	BG105128A (en)
BR (1)	BR9911357A (en)
CA (1)	CA2335112A1 (en)
CO (1)	CO5070586A1 (en)
EA (1)	EA200001189A1 (en)
GT (1)	GT199900083A (en)
HR (1)	HRP20000857A2 (en)
HU (1)	HUP0102395A2 (en)
ID (1)	ID26726A (en)
IL (1)	IL139587A0 (en)
IS (1)	IS5727A (en)
MA (1)	MA26648A1 (en)
NO (1)	NO20006381D0 (en)
OA (1)	OA11569A (en)
PA (1)	PA8472101A1 (en)
PE (1)	PE20000633A1 (en)
PL (1)	PL345064A1 (en)
SK (1)	SK18902000A3 (en)
TN (1)	TNSN99118A1 (en)
UY (1)	UY25557A1 (en)
WO (1)	WO1999065488A1 (en)
ZA (1)	ZA993973B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1004306A3 (en) *	1998-08-06	2000-06-07	Pfizer Products Inc.	Estrogen agonists/antagonists
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
WO2002017918A2 (en)	2000-08-30	2002-03-07	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
US7524866B2 (en)	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
SI1666033T1 (en) *	2001-11-29	2009-06-30	Gtx Inc	Prevention and treatment of androgen-deprivation induced osteoporosis
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EA200901077A1 (en)	2007-02-09	2010-04-30	Транзим Фарма, Инк.	MACRO CYCLIC MODULATORS OF THE GREEL RECEPTOR AND THEIR APPLICATION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (en) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS

1999
- 1999-05-03 ID IDW20002604A patent/ID26726A/en unknown
- 1999-05-03 EA EA200001189A patent/EA200001189A1/en unknown
- 1999-05-03 SK SK1890-2000A patent/SK18902000A3/en unknown
- 1999-05-03 AU AU33420/99A patent/AU3342099A/en not_active Abandoned
- 1999-05-03 EP EP99914723A patent/EP1085867A1/en not_active Withdrawn
- 1999-05-03 WO PCT/IB1999/000796 patent/WO1999065488A1/en not_active Application Discontinuation
- 1999-05-03 HU HU0102395A patent/HUP0102395A2/en unknown
- 1999-05-03 IL IL13958799A patent/IL139587A0/en unknown
- 1999-05-03 KR KR1020007014140A patent/KR20010052817A/en not_active Application Discontinuation
- 1999-05-03 OA OA1200000346A patent/OA11569A/en unknown
- 1999-05-03 JP JP2000554368A patent/JP2002518328A/en active Pending
- 1999-05-03 PL PL99345064A patent/PL345064A1/en unknown
- 1999-05-03 CN CN99807381A patent/CN1305378A/en active Pending
- 1999-05-03 BR BR9911357-0A patent/BR9911357A/en not_active Application Discontinuation
- 1999-05-03 CA CA002335112A patent/CA2335112A1/en not_active Abandoned
- 1999-05-07 PA PA19998472101A patent/PA8472101A1/en unknown
- 1999-06-10 AP APAP/P/1999/001581A patent/AP9901581A0/en unknown
- 1999-06-11 PE PE1999000522A patent/PE20000633A1/en not_active Application Discontinuation
- 1999-06-11 UY UY25557A patent/UY25557A1/en not_active Application Discontinuation
- 1999-06-14 GT GT199900083A patent/GT199900083A/en unknown
- 1999-06-15 ZA ZA9903973A patent/ZA993973B/en unknown
- 1999-06-15 AR ARP990102847A patent/AR018868A1/en not_active Application Discontinuation
- 1999-06-15 MA MA25622A patent/MA26648A1/en unknown
- 1999-06-15 TN TNTNSN99118A patent/TNSN99118A1/en unknown
- 1999-06-16 CO CO99037624A patent/CO5070586A1/en unknown
2000
- 2000-11-24 IS IS5727A patent/IS5727A/en unknown
- 2000-12-14 NO NO20006381A patent/NO20006381D0/en not_active Application Discontinuation
- 2000-12-14 HR HR20000857A patent/HRP20000857A2/en not_active Application Discontinuation
2001
- 2001-01-08 BG BG105128A patent/BG105128A/en unknown

Also Published As

Publication number	Publication date
SK18902000A3 (en)	2001-12-03
PA8472101A1 (en)	2000-09-29
OA11569A (en)	2004-07-01
AR018868A1 (en)	2001-12-12
CO5070586A1 (en)	2001-08-28
KR20010052817A (en)	2001-06-25
PE20000633A1 (en)	2000-07-26
WO1999065488A1 (en)	1999-12-23
GT199900083A (en)	2000-12-05
NO20006381L (en)	2000-12-14
HRP20000857A2 (en)	2001-10-31
BR9911357A (en)	2001-03-13
HUP0102395A2 (en)	2001-11-28
CA2335112A1 (en)	1999-12-23
CN1305378A (en)	2001-07-25
BG105128A (en)	2001-11-30
AP9901581A0 (en)	1999-06-30
JP2002518328A (en)	2002-06-25
EP1085867A1 (en)	2001-03-28
PL345064A1 (en)	2001-11-19
EA200001189A1 (en)	2001-06-25
ZA993973B (en)	2000-12-15
TNSN99118A1 (en)	2005-11-10
UY25557A1 (en)	2001-01-31
ID26726A (en)	2001-02-01
IL139587A0 (en)	2002-02-10
NO20006381D0 (en)	2000-12-14
AU3342099A (en)	2000-01-05
MA26648A1 (en)	2004-12-20

Similar Documents

Publication	Publication Date	Title
IS2595B (en)	2010-03-15	Protein blend and process for isolating protein mixture from muscle tissue
DE69925507D1 (en)	2005-06-30	EXPANDABLE ARC DEVICE FOR APPLICATION TO HARNINE CONTINENCE AND METHOD OF MANUFACTURE THEREOF
DK0946190T3 (en)	2003-12-08	Methods and Compositions for Stimulating Neurite Growth
EP1143987A4 (en)	2004-09-22	Natural composition and method for the treatment of sexual dysfunction
ID23496A (en)	2000-04-27	PLANT EXTRACT TO TREAT IMPROVEMENT OF BONE RESORTS
IS2390B (en)	2008-08-15	Method of removing muscle meat from fish and equipment to perform that method
PL338558A1 (en)	2000-11-06	Controllably released fertilisers and method of obtaining them
EP1071841A4 (en)	2001-07-04	Method and apparatus for countercurrent treatment of slurries
DK0898894T3 (en)	2003-06-10	Semi-automatic device for boning of piglet and method for boning of piglet using the same
IS5727A (en)	2000-11-24	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness
ZA984172B (en)	1998-11-25	Method of water treatment using zeolite crystalloid coagulants
NO983641D0 (en)	1998-08-07	METHOD OF TREATMENT AND PHARMACEUTICAL PREPARATION
DK3497A (en)	1997-07-11	Sustained release formulation of an animal growth hormone and process for its preparation
IS5691A (en)	2000-10-27	Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness
GB2333290B (en)	1999-12-08	Method of water treatment using zeolite crystalloid coagulants
IL147008A0 (en)	2002-08-14	Mixing apparatus and method of mixing
EP1296889A4 (en)	2007-03-07	Plasticizable mixture and method of using
BR9508718A (en)	1997-12-30	Establishment and method for segregation of ovarian tonic estrogen for extended therapeutic regimens
NO982112L (en)	1998-11-16	Mixed dose mixture, of an angiotensin converting enzyme inhibitor and a calcium channel antagonist, method of preparation and use thereof in the treatment of cardiovascular diseases
NO20032969D0 (en)	2003-06-27	Method of Screening for Progesterone Receptor Isoform-Specific Ligands and for Tissue Selective Progesterone Receptor Ligands
PL336422A1 (en)	2000-06-19	Method of and apparatus for preparing asphalt mixes
EP1009433A4 (en)	2005-03-16	Therapeutic composition and method of treatment
DK1244662T3 (en)	2005-07-11	Pyridazinoquinoline derivatives and method of treating pain
IS6428A (en)	2002-06-19	Method and mix to treat pain
GB0010430D0 (en)	2000-06-14	Method and apparatus for non-manual installation of software,such as NT services